ABSTRACT
INTRODUCTION: Abstract thinking is important in modern understanding of neurocognitive abilities, and a symptom of thought disorder in psychosis. In patients with psychosis, we assessed if socio-developmental background influences abstract thinking, and the association with executive functioning and clinical psychosis symptoms. METHODS: Participants (n = 174) had a diagnosis of psychotic or bipolar disorder, were 17-65 years, intelligence quotient (IQ) > 70, fluent in a Scandinavian language, and their full primary education in Norway. Immigrants (N = 58) were matched (1:2) with participants without a history of migration (N = 116). All participants completed a neurocognitive and clinical assessment. Socio-developmental background was operationalised as human developmental index (HDI) of country of birth, at year of birth. Structural equation modelling was used to assess the model with best fit. RESULTS: The model with best fit, χ2 = 96.591, df = 33, p < .001, confirmed a significant indirect effect of HDI scores on abstract thinking through executive functioning, but not through clinical psychosis symptoms. CONCLUSIONS: This study found that socio-developmental background influences abstract thinking in psychosis by indirect effect through executive functioning. We should take into account socio-developmental background in the interpretation of neurocognitive performance in patients with psychosis, and prioritise cognitive remediation in treatment of immigrant patients.
Subject(s)
Bipolar Disorder/psychology , Cognition Disorders/psychology , Psychotic Disorders/psychology , Thinking , Adolescent , Adult , Aged , Bipolar Disorder/ethnology , Cognition Disorders/ethnology , Emigrants and Immigrants/psychology , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Norway , Psychiatric Status Rating Scales , Psychotic Disorders/ethnology , Young AdultABSTRACT
OBJECTIVE: To investigate potential risk factors for medication non-adherence in patients with schizophrenia and bipolar disorder. METHOD: A total of 255 patients underwent clinical assessments, neurocognitive testing and blood sampling. The patients were divided into groups of 'No', 'Partial' or 'Full' adherence. Relationships to different risk factors were analyzed. RESULTS: In schizophrenia, use of illicit substances, alcohol and poor insight were related to worse adherence. Schizophrenia patients with No adherence did better on tests of executive functioning, verbal learning and memory and had higher IQ than patients with better adherence. There were higher levels of autonomic side effects in the non-adherence group, but body mass index was lower in the Partial adherence group than in the Full adherence group. In the bipolar disorder patients, there was an association between the use of illicit substances and alcohol and poor adherence. We found no relationship between adherence behavior and neurocognition in the bipolar disorder group. CONCLUSION: Substance use is an important risk factor for non-adherence in patients with schizophrenia and bipolar disorder. Poor insight is also a risk factor in schizophrenia. The results suggest that cognitive dysfunction is not a risk factor for non-adherence in these diagnostic groups.
Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Medication Adherence/statistics & numerical data , Schizophrenia/drug therapy , Adult , Cognition Disorders/epidemiology , Cognition Disorders/etiology , Cohort Studies , Cross-Sectional Studies , Executive Function , Female , Humans , Intelligence Tests/statistics & numerical data , Male , Memory , Middle Aged , Neuropsychological Tests/statistics & numerical data , Norway/epidemiology , Psychotic Disorders/complications , Psychotic Disorders/drug therapy , Risk Factors , Substance-Related Disorders/epidemiology , Verbal Learning , Young AdultABSTRACT
BACKGROUND: Cannabis use is associated with altered neurocognitive functioning in severe mental disorders, but data are still inconclusive and there are no studies of bipolar disorder. The aim of this study was to investigate the association between cannabis use and neurocognition in bipolar disorder compared with schizophrenia in a naturalistic setting. METHOD: A total of 133 patients with bipolar disorder and 140 patients with schizophrenia underwent neuropsychological assessments and clinical characterization including measures of substance use. Relationships between cannabis users and neurocognitive function were explored in the two diagnostic groups. Possible interactions between diagnosis and cannabis use were investigated, and findings were controlled for possible confounders. RESULTS: In bipolar disorder subjects, cannabis use was associated with better neurocognitive function, but the opposite was the case for the schizophrenia subjects. There was a statistically significant interaction effect of diagnosis and cannabis use on focused attention (p=0.019), executive functioning (verbal fluency--set shifting) (p=0.009), logical memory-learning (p=0.007) and on logical memory-recall (p=0.004). These differences in neurocognitive function could not be explained by putative confounders. CONCLUSIONS: The findings suggest that cannabis use may be related to improved neurocognition in bipolar disorder and compromised neurocognition in schizophrenia. The results need to be replicated in independent samples, and may suggest different underlying disease mechanisms in the two disorders.
Subject(s)
Bipolar Disorder/diagnosis , Bipolar Disorder/psychology , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Marijuana Abuse/diagnosis , Marijuana Abuse/psychology , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Schizophrenia/diagnosis , Schizophrenic Psychology , Adult , Attention/drug effects , Executive Function/drug effects , Female , Humans , Male , Memory, Short-Term/drug effects , Middle Aged , Neuropsychological Tests/statistics & numerical data , Psychometrics , Psychomotor Performance/drug effects , Verbal Learning/drug effects , Young AdultABSTRACT
OBJECTIVE: There is conflicting data on drug abuse and outcome in severe mental illness. This study aims to investigate if the amount of illicit psychoactive drug use is related to symptom load or premorbid functioning across diagnosis in patients with severe mental illness. METHOD: Symptom load, sociodemographic status, premorbid functioning and the level of use of illicit psychoactive drugs were assessed in 423 subjects with schizophrenia or bipolar disorder in a cross-sectional study. RESULTS: High amount of illicit drug use was associated with poorer premorbid academic functioning. In schizophrenia, there was a significant positive association between amount of drug use and severity of psychiatric symptoms. The association between symptom load and drug use was significant after controlling for premorbid functioning. CONCLUSION: The results suggest a direct association between the quantity of current drug use and more severe symptoms in schizophrenia. Poor premorbid functioning was related to high amount of use, but did not explain the difference in symptom load.
Subject(s)
Adaptation, Psychological/drug effects , Illicit Drugs , Mental Disorders/psychology , Substance-Related Disorders/psychology , Adult , Bipolar Disorder/epidemiology , Bipolar Disorder/psychology , Comorbidity , Cross-Sectional Studies , Educational Status , Female , Humans , Male , Mental Disorders/epidemiology , Norway/epidemiology , Psychiatric Status Rating Scales , Schizophrenia/epidemiology , Schizophrenic Psychology , Severity of Illness Index , Sex Distribution , Social Adjustment , Socioeconomic Factors , Substance-Related Disorders/epidemiologyABSTRACT
OBJECTIVE: Prevalence estimates of illicit drug use in psychotic disorders vary between studies, and only a few studies compared prevalence estimates with those in the general population. METHOD: Cross-sectional study comparing 148 stable-phase patients with schizophrenia or bipolar disorder with 329 representative general citizens of Oslo. A total of 849 patients from the same hospital department in the same time period constituted a patient reference group. RESULTS: Lifetime illicit drug use was 44% higher (P < 0.001) in study patients than in the general population sample; while lifetime use of amphetamine/cocaine was 160% higher (P < 0.001). No differences were found between user groups for sociodemographic characteristics. CONCLUSION: Patients with psychotic disorders in stable phase had a markedly higher lifetime use of any illicit substance, especially amphetamine/cocaine, than the general population. They also seemed to use drugs more periodically. The same sociodemographic characteristics were associated with increased illicit drug use in both groups.
Subject(s)
Illicit Drugs , Psychotic Disorders/epidemiology , Substance-Related Disorders/epidemiology , Acute Disease , Adolescent , Adult , Aged , Catchment Area, Health , Cross-Sectional Studies , Diagnosis, Dual (Psychiatry) , Diagnostic and Statistical Manual of Mental Disorders , Female , Humans , Male , Middle Aged , Norway/epidemiology , Population Surveillance , Prevalence , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Severity of Illness Index , Substance-Related Disorders/diagnosis , Substance-Related Disorders/psychologyABSTRACT
OBJECTIVE: Impaired emotion perception is documented for schizophrenia, but findings have been mixed for bipolar disorder. In healthy samples females perform better than males. This study compared emotion perception in schizophrenia and bipolar disorder and investigated the effects of gender. METHOD: Visual (facial pictures) and auditory (sentences) emotional stimuli were presented for identification and discrimination in groups of participants with schizophrenia, bipolar disorder and healthy controls. RESULTS: Visual emotion perception was unimpaired in both clinical groups, but the schizophrenia sample showed reduced auditory emotion perception. Healthy males and male schizophrenia subjects performed worse than their female counterparts, whereas there were no gender differences within the bipolar group. CONCLUSION: A disease-specific auditory emotion processing deficit was confirmed in schizophrenia, especially for males. Participants with bipolar disorder performed unimpaired.